Form 4: Vor Biopharma Executive Chakraborty Reports Stock Disposals for Tax Obligations

Tirtha Chakraborty, Chief Scientific Officer & Head of Technical Operations at Vor Biopharma, reported disposing of shares to cover tax withholding obligations related to the settlement of restricted stock units.

Summary

• On May 1, 2025, Tirtha Chakraborty, Chief Scientific Officer & Head of Technical Operations at Vor Biopharma Inc., disposed of 985 shares of common stock at $0.66 per share to cover tax obligations.
• Additionally, Chakraborty disposed of 962 shares of common stock, also at $0.66 per share, for the same reason.
• Following these transactions, Chakraborty directly owns 218,292 shares of Vor Biopharma Inc.
• The disposals were executed to satisfy tax withholding obligations related to the settlement of restricted stock units.

Sentiment

Score: 5

Explanation: Neutral sentiment as the filing reflects routine tax-related stock disposals, which are a normal part of executive compensation.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential sentiment.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are related to tax obligations and do not indicate a change in the executive's long-term outlook on the company.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Disposal, Tax Withholding, Restricted Stock Units, VOR, Vor Biopharma, Chakraborty, Insider Trading